Evaluation of outcome of disease in COVID-19 patients with Comorbidities: An experience from a Tertiary Care Center in North India

Author:

Sharma Suman1,Singh Deepinder2,Katyal Ashima2,S. Gill Paramjeet3,Jangra Surender4,Bhardwaj Bhupender3,Bhocal Usha3

Affiliation:

1. Department of Pathology, Post Graduate Institute of Medical Sciences (PGIMS), Rohtak - 124001, India.

2. Department of Microbiology, Kalpana Chawla Government Medical College, Karnal, India.

3. Department of Microbiology, Post Graduate Institute of Medical Sciences (PGIMS), Rohtak - 124001, India.

4. Department of Chemistry and Biochemistry, Sharda School of basic sciences and Research, Sharda university, Greater Noida, India.

Abstract

The data on the poor outcomes of COVID-19 patients pertaining to their comorbidities is scarce in Indian population. We studied 331 COVID-19 patients admitted to PGIMS, Rohtak, of which 106 were with comorbidities and 225 patients without any comorbid conditions (controls). Among 225 patients without comorbidities, the average length of stay in hospital was ~3.9 days, while patients (n=106) with comorbidities stayed for almost double time (average 7.4 days). Among 106 hospitalized patients with comorbidities, 61 (57.4%) received oxygen support, with an average intake of 6.5 L/min of oxygen, while 29 of 225 (12.8%) controls received an average 3.1 L/min of oxygen. Out 106 patients with comorbidities 49 (46.2%) required ICU admission compared to 18 (8%) of 225 controls. The mortality in patients with comorbidities was 35.8% (38/106), which was higher than patients with no comorbidities (5.7%, 13/225). The Kaplan-Meier survival curve indicated poor survival trends in COVID-19 patients with comorbidities, as compared to those without comorbidities. Overall, this study demonstrates that comorbidities, like diabetes, hypertension, chronic cardiac disease, chronic kidney disease, chronic pulmonary, thyroid disorders, etc. are associated with severe COVID-19 disease progression.

Publisher

A and V Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3